Source: Eur Respir J , 49 (3) 1601976; DOI: 10.1183/13993003.01976-2016
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Arisu Kamada, Masaru Amishima. QuantiFERON-TB® Gold Plus as a potential tuberculosis treatment monitoring tool. Eur Respir J , 49 (3) 1601976; DOI: 10.1183/13993003.01976-2016

Member's Comments

No comment yet.

Related content which might interest you: Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 First evaluation of QuantiFERON-TB Gold Plus performance in contact screening Source: Eur Respir J 2016; 48: 1411-1419 Year: 2016 Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 A comparison of QuantiFERON-TB Gold In-Tube test and new QuantiFERON-Microtube assay in children suspect of active TB and adults with active TB Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold In tube test Source: Eur Respir Rev 2008; 17: 74-75 Year: 2008 Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold in tube test Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Role of the QuantiFERON®-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection Source: Eur Respir J 2012; 40: 1443-1449 Year: 2012 First independent evaluation of QuantiFERON-TB Plus performance Source: Eur Respir J 2016; 47:1587-1590 Year: 2016 Evaluation of QuantiFERON microtube, using 0.9 mL blood, for diagnosing tuberculosis infection Source: Eur Respir J 2013; 41: 909-916 Year: 2013 The QuantiFERON-TB Gold test at HIV patients Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 Evaluation of usefulness of QuantiFERON®-TB Gold for infants Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2012; 39: 163-171 Year: 2012 Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2011; 39: 163-171 Year: 2012 QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 Use of QuantiFERON-TB gold test in diagnosis of active tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 140s Year: 2006 Sensitivity of the QuantiFERON-TB Gold test in culture-verified NTM disease and TB in a Danish setting Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Comparison of the accuracy of QuantiFERON TB gold in tube vs QuantiFERON-TB plus Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Evaluation of QuantiFERON-TB Gold Assay in detecting latent and active infection with mycobacterium tuberculosis in group of Egyptian children Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 Interferon-gamma response by years after tuberculosis infection, measured with QuantiFERON-TB Plus Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Evaluation of the QuantiFERON-TB Gold in tube cut-off for diagnosing tuberculosis in HIV-infected and non-HIV infected individuals Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2012